mhurhangee/ep-ind-claims huggingface dataset:
Connection device comprising: - a socket body qualified according to a first standard as satisfying the requirements for withstanding harsh environments, the socket body being hollow and intended to be attached to a panel of on-board equipment, the socket body comprising an attachment plate; - an external connector rigidly housed in the socket body, the external connector being defined according to a second standard that is different from the first standard, said external connector not being qualified as satisfying the requirements of the first standard; - an internal connector linked to the external connector, said internal connector being adapted to be connected to a board of the on-board equipment; - a flexible, impedance-matched transition (24, 25, 25') housed at least partially in the socket body and positioned between the external connector and the internal connector, which is configured, when in operation, to match the impedance of the lines passing between the internal connector and the external connector, the transition comprising a flexible circuit connecting, by means of controlled impedance lines, a first printed circuit supporting the external connector and a second circuit supporting the internal connector; - a support plate supporting the first circuit, said support plate being attached to the attachment plate of the socket body, said flexible circuit extending from the support plate to the internal connector. - a socket body qualified according to a first standard as satisfying the requirements for withstanding harsh environments, the socket body being hollow and intended to be attached to a panel of on-board equipment, the socket body comprising an attachment plate; - an external connector rigidly housed in the socket body, the external connector being defined according to a second standard that is different from the first standard, said external connector not being qualified as satisfying the requirements of the first standard; - an internal connector linked to the external connector, said internal connector being adapted to be connected to a board of the on-board equipment; - a flexible, impedance-matched transition (24, 25, 25') housed at least partially in the socket body and positioned between the external connector and the internal connector, which is configured, when in operation, to match the impedance of the lines passing between the internal connector and the external connector, the transition comprising a flexible circuit connecting, by means of controlled impedance lines, a first printed circuit supporting the external connector and a second circuit supporting the internal connector; - a support plate supporting the first circuit, said support plate being attached to the attachment plate of the socket body, said flexible circuit extending from the support plate to the internal connector.
Batch method for impregnating a polymeric pharmaceutical carrier with an active substance, characterised in that it comprises the following consecutive steps: a) mixing the active substance and the non-porous polymeric pharmaceutical carrier, the pharmaceutical carrier being in solid form and insoluble in supercritical CO 2 and not being non-cross-linked polyvinylpyrrolidone; b) performing a molecular diffusion step in the absence of water by contacting, in static mode without stirring, the mixture obtained in step a) with supercritical CO 2 at a pressure between 80 and 170 bar and at a temperature between 31 and 90°C for between 1 and 6 hours, c) recovering the polymeric pharmaceutical carrier impregnated with the active substance obtained in step b), the impregnated pharmaceutical carrier being non-porous and being in solid form and the active substance being in amorphous form, and in that the method is implemented in the absence of an additional solvent. a) mixing the active substance and the non-porous polymeric pharmaceutical carrier, the pharmaceutical carrier being in solid form and insoluble in supercritical CO 2 and not being non-cross-linked polyvinylpyrrolidone; b) performing a molecular diffusion step in the absence of water by contacting, in static mode without stirring, the mixture obtained in step a) with supercritical CO 2 at a pressure between 80 and 170 bar and at a temperature between 31 and 90°C for between 1 and 6 hours, c) recovering the polymeric pharmaceutical carrier impregnated with the active substance obtained in step b), the impregnated pharmaceutical carrier being non-porous and being in solid form and the active substance being in amorphous form,
A sheet processor device comprising a frame defining a processing path having a sheet inlet and a sheet outlet, a feed tray mounted on the frame in the vicinity of the inlet, a feed roller projecting into the tray, a first separator roller and a second separator roller mounted facing each other and projecting into the processing path in the vicinity of the inlet, a first motor connected to the first separator roller and to the feed roller, and a second motor connected to the second separator roller, the device being characterized in that a driver member is arranged to power the second motor as a function of a predetermined maximum threshold for electricity power supply, and in that the driver member is connected to a control unit arranged to store and process a signal representative of inequality between the electricity power supply and the predetermined maximum threshold, in such a manner as to diagnose the operation of the device.
A fluid analyzing device, comprising: - a sensing device for analyzing a fluid sample, comprising: a microchip configured for sensing the fluid sample and a micro-fluidic component (4,102) for propagating the fluid sample to the microchip, - an inlet connected to the micro-fluidic component (4,102) for providing the fluid sample to the micro-fluidic component (4,102), wherein the micro-fluidic component (4,102), aside from its connection to the inlet, further is closed thus forming a closed micro-fluidic component (4,102), the fluid analyzing device further comprising - a vacuum compartment air-tight connected to the sensing device and adapted for creating a suction force in the micro-fluidic component (4,102) suitable for propagating the fluid sample through the micro-fluidic component (4,102) when provided in the micro-fluidic component (4,102), by opening the vacuum compartment characterised in that the fluid analyzing device comprises a fluid detector positioned to detect the fluid sample when provided in the micro-fluidic component (4,102), and wherein the vacuum compartment is configured to open when the fluid sample is detected. - a sensing device for analyzing a fluid sample, comprising: a microchip configured for sensing the fluid sample and a micro-fluidic component (4,102) for propagating the fluid sample to the microchip, - an inlet connected to the micro-fluidic component (4,102) for providing the fluid sample to the micro-fluidic component (4,102), wherein the micro-fluidic component (4,102), aside from its connection to the inlet, further is closed thus forming a closed micro-fluidic component (4,102), the fluid analyzing device further comprising - a vacuum compartment air-tight connected to the sensing device and adapted for creating a suction force in the micro-fluidic component (4,102) suitable for propagating the fluid sample through the micro-fluidic component (4,102) when provided in the micro-fluidic component (4,102), by opening the vacuum compartment characterised in that the fluid analyzing device comprises a fluid detector positioned to detect the fluid sample when provided in the micro-fluidic component (4,102), and wherein the vacuum compartment is configured to open when the fluid sample is detected.
A system for verifying an image level backup, the system comprising: a virtual storage connected to a hypervisor, the hypervisor configured to access the image level backup and receive a selection of a data object from the image level backup file to verify, wherein the data object is associated with an application; a test virtual machine, VM, hosting the application, wherein the hypervisor is configured to launch the test VM using data files from the image level backup; a changes storage storing test VM virtual disk data changes inflicted by running the test VM, wherein the changes storage is implemented using virtual storage logic; a verification module configured to execute tests using the selected data object and its associated application in the test VM; and a data conversion engine configured to perform on-demand decompression, de-deduplication, decryption of the image level backup to extract the data object so as to provide contents of the data object to the hypervisor without fully extracting contents of the image level backup. a virtual storage connected to a hypervisor, the hypervisor configured to access the image level backup and receive a selection of a data object from the image level backup file to verify, wherein the data object is associated with an application; a test virtual machine, VM, hosting the application, wherein the hypervisor is configured to launch the test VM using data files from the image level backup; a changes storage storing test VM virtual disk data changes inflicted by running the test VM, wherein the changes storage is implemented using virtual storage logic; a verification module configured to execute tests using the selected data object and its associated application in the test VM; and a data conversion engine configured to perform on-demand decompression, de-deduplication, decryption of the image level backup to extract the data object so as to provide contents of the data object to the hypervisor without fully extracting contents of the image level backup.
An operating method for a vehicle, comprising the steps: - determining of a filling value of a liquid in a container of the vehicle at a first time and at a second time, - calculating of the difference between the filling value at the first time and the filling value at the second time, in order to obtain a close-to-reality liquid decrease between the first time and the second time, - comparing of the close-to-reality liquid decrease with a reference quantity which is preferably required to achieve a defined reduction of pollutants in the exhaust gas of the vehicle, and - generating of an operating restriction of the vehicle if the liquid decrease undershoots the reference quantity, preferably by a predefined amount and/or over a defined time span. - determining of a filling value of a liquid in a container of the vehicle at a first time and at a second time, - calculating of the difference between the filling value at the first time and the filling value at the second time, in order to obtain a close-to-reality liquid decrease between the first time and the second time, - comparing of the close-to-reality liquid decrease with a reference quantity which is preferably required to achieve a defined reduction of pollutants in the exhaust gas of the vehicle, and - generating of an operating restriction of the vehicle if the liquid decrease undershoots the reference quantity, preferably by a predefined amount and/or over a defined time span.
A method of making a cube corner article, comprising: providing a body layer having a structured surface that includes recessed faces defining cube corner cavities; applying a film of reflective material to the recessed faces; applying to the structured surface a radiation-curable composition suitable for bonding to the film of reflective material; and exposing the composition to radiation sufficient to crosslink the composition after the composition has filled the cube corner cavities. providing a body layer having a structured surface that includes recessed faces defining cube corner cavities; applying a film of reflective material to the recessed faces; applying to the structured surface a radiation-curable composition suitable for bonding to the film of reflective material; and exposing the composition to radiation sufficient to crosslink the composition after the composition has filled the cube corner cavities.
A method performed by a software defined network controller, the software defined network controller being for a network comprising a plurality of network elements (30 A-F) in communication with the controller, each of the network elements (30 A-F) capable of serving as a point of attachment of a virtual or physical host, the method comprising detecting when a host (40-A) has roamed from a first network element (30-A)to a second network element (30-B); updating a roaming path for the host (40-A) in response to detecting that the host (40-A) has roamed to the second network element (30-B); and sending commands to the network elements (30 A-F) in the roaming path in reverse order of the roaming path in order to program a tunnel from each previous point of attachment network element in the roaming path to the most recent network element in the roaming path in reverse order of the roaming path so as to route traffic for the host (40-A) via a tunnel.
A method of stabilizing a biomimetic membrane comprising a membrane protein selected from an aquaporin or an aquaglyceroporin (GLpF), the method comprising adding a Class II hydrophobin to the biomimetic membrane, wherein the Class II hydrophobin is added at a concentration of 0.1% to 20% by weight of the total membrane.
Method of accessing in a telecommunication network a Network Based Personal Data Storage, NB-PDS, associated with a User Equipment, UE,, said method using at least a control server and a Personal Data Storage Server, PDSS, enabling access to said NB-PDS, said method comprising the steps of: - transmitting, by said UE, to said control server, an indication of supporting NB-PDS functionality; - retrieving, by said control server, in response to receiving said indication, an Access Point Name, APN, of an access point server, for accessing said PDSS through a data bearer connection in said telecommunication network; - establishing, under control of said control server, said data bearer connection between said UE and said access point server; - establishing, under control of said access point server, a data connection between said UE and said PDSS over said data bearer connection providing data access by said UE to said associated NB-PDS, and - presenting, by said UE, a file directory of said associated NB-PDS in a file directory structure of said UE, characterized in that said telecommunication network comprises said control server and said PDSS, wherein said telecommunication network is a telecommunication network under control of a telecommunication network operator and not including a public based data network like the internet, and wherein said PDSS is a subscription database comprising subscription records of UEs and only accessible via said telecommunication network. - transmitting, by said UE, to said control server, an indication of supporting NB-PDS functionality; - retrieving, by said control server, in response to receiving said indication, an Access Point Name, APN, of an access point server, for accessing said PDSS through a data bearer connection in said telecommunication network; - establishing, under control of said control server, said data bearer connection between said UE and said access point server; - establishing, under control of said access point server, a data connection between said UE and said PDSS over said data bearer connection providing data access by said UE to said associated NB-PDS, and - presenting, by said UE, a file directory of said associated NB-PDS in a file directory structure of said UE, characterized in that said telecommunication network comprises said control server and said PDSS, wherein said telecommunication network is a telecommunication network under control of a telecommunication network operator and not including a public based data network like the internet, and wherein said PDSS is a subscription database comprising subscription records of UEs and only accessible via said telecommunication network.
A method for producing a wet pet food having enhanced palatability comprising: a) adding to a wet pet food, from 0.5% to 10% of a wet pet food palatability-enhancing composition comprising at least: - one or more free amino acids A1, - one or more sugars A2, and - one or more inorganic phosphate compounds B with an amount P of phosphorus, wherein the amount P of phosphorus is from 1% to 5% based on the total weight of said wet pet food palatability-enhancing composition, and wherein the ratio R1 of A1/(A1+A2+P) is superior to 0.30 and inferior to 0.45; and b) obtaining a wet pet food having enhanced palatability. a) adding to a wet pet food, from 0.5% to 10% of a wet pet food palatability-enhancing composition comprising at least: - one or more free amino acids A1, - one or more sugars A2, and - one or more inorganic phosphate compounds B with an amount P of phosphorus, wherein the amount P of phosphorus is from 1% to 5% based on the total weight of said wet pet food palatability-enhancing composition, and wherein the ratio R1 of A1/(A1+A2+P) is superior to 0.30 and inferior to 0.45; and - one or more free amino acids A1, - one or more sugars A2, and - one or more inorganic phosphate compounds B with an amount P of phosphorus, wherein the amount P of phosphorus is from 1% to 5% based on the total weight of said wet pet food palatability-enhancing composition, and b) obtaining a wet pet food having enhanced palatability.
Sander especially for sanding curved surface areas, comprises an elongate body (1, 17) to which a grinding plate is movably attached, and a power unit for driving the movable grinding plate to provide its grinding motion, characterized by at least two movable lever beams (9, 20) attached to the body (1, 17) one apart from another, the lever beams (9, 20) being provided with two opposite ends, a flexible grinding plate being attached to said ends over flexible connecting elements (10, 21), in order to provide the flexible grinding plate with relative and defined linear or orbital motion in relation to the body (1, 17).
A pharmaceutical composition as an oat extract for use in prevention or treatment of Alzheimer's disease, comprising avenanthramide C represented by Formula 1 below or a derivative thereof: wherein the derivative of avenanthramide C is avenanthramide C methyl ester represented by Formula 2 below: wherein the pharmaceutical composition is for nasal administration in a unit-dose spray amount of 20 to 500 μg.
A method for determining pH values of fermented/acidified milk/vegetable milk products from inline optical measurements, the method comprising: a. emitting light into a fermented/acidified animal/vegetable milk product; b. optically detecting scattering light coming from said fermented/acidified animal/vegetable milk product, generated from said emitted light once received therein, to collect scattered light data; c. calculating, by a computing device including one or more processors running an algorithm, at least one value of a variable from the collected scattered light data, said variable comprising a light backscatter ratio at a given time; and d. obtaining, by said computing device, a pH value of the fermented/acidified animal/vegetable milk product using said at least one calculated value of said variable, wherein said pH value is ≤ 5.2, and wherein a single wavelength is used for collecting the scattered light data. a. emitting light into a fermented/acidified animal/vegetable milk product; b. optically detecting scattering light coming from said fermented/acidified animal/vegetable milk product, generated from said emitted light once received therein, to collect scattered light data; c. calculating, by a computing device including one or more processors running an algorithm, at least one value of a variable from the collected scattered light data, said variable comprising a light backscatter ratio at a given time; and d. obtaining, by said computing device, a pH value of the fermented/acidified animal/vegetable milk product using said at least one calculated value of said variable, wherein said pH value is ≤ 5.2, and wherein a single wavelength is used for collecting the scattered light data.
A method for producing a composition containing a highly unsaturated fatty acid or alkyl ester thereof, which comprises: alkyl esterifying a raw material containing a triglyceride comprising a highly unsaturated fatty acid as constituent fatty acid, to prepare a composition containing a highly unsaturated fatty acid alkyl ester; at least one selected from among: (a) reducing to less than 10,000 ppm the concentration in the composition prepared in step of monoacyl glycerol that comprises as constituent fatty acid a fatty acid that has 5 or more carbon atoms fewer than the highly unsaturated fatty acid that constitutes the highly unsaturated fatty acid alkyl ester to be enriched, (b) reducing the iron concentration in the composition prepared in step to less than 0.20 ppm, and (c) reducing the chlorine concentration in the composition prepared in step to less than 10 ppm; and distilling the composition resulting from step and collecting the main distillate fraction. alkyl esterifying a raw material containing a triglyceride comprising a highly unsaturated fatty acid as constituent fatty acid, to prepare a composition containing a highly unsaturated fatty acid alkyl ester; at least one selected from among: (a) reducing to less than 10,000 ppm the concentration in the composition prepared in step of monoacyl glycerol that comprises as constituent fatty acid a fatty acid that has 5 or more carbon atoms fewer than the highly unsaturated fatty acid that constitutes the highly unsaturated fatty acid alkyl ester to be enriched, (b) reducing the iron concentration in the composition prepared in step to less than 0.20 ppm, and (c) reducing the chlorine concentration in the composition prepared in step to less than 10 ppm; and (a) reducing to less than 10,000 ppm the concentration in the composition prepared in step of monoacyl glycerol that comprises as constituent fatty acid a fatty acid that has 5 or more carbon atoms fewer than the highly unsaturated fatty acid that constitutes the highly unsaturated fatty acid alkyl ester to be enriched, (b) reducing the iron concentration in the composition prepared in step to less than 0.20 ppm, and (c) reducing the chlorine concentration in the composition prepared in step to less than 10 ppm; and distilling the composition resulting from step and collecting the main distillate fraction.
A pharmaceutical composition for cancer treatment, capable of strengthening the anti-cancer effect of Capecitabine and reducing side effects, characterized in that the pharmaceutical composition comprises an effective dose of Capecitabine with an anti-cancer effect, an effective dose of Gimeracil with an anti-cancer synergy, and an effective dose of Oteracil potassium for reducing side effects.